WitrynaDec-10-21 06:26AM. Insiders who bought Immunic, Inc. (NASDAQ:IMUX) stock in the last 12 months recover some losses, but still down US$82k. Simply Wall St. Dec-09-21 04:01PM. Immunic, Inc. Announces Enrollment of the First Patient in its Phase 1 Trial of IMU-935 in Metastatic Castration-Resistant Prostate Cancer. Witryna17 lis 2024 · NEW YORK, Nov. 17, 2024 /PRNewswire/ --Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral …
Immunic Reports Positive Data from Maintenance Phase of Phase …
Witryna17 lis 2024 · November 17, 2024. NEW YORK, Nov. 17, 2024 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a … Witryna5 kwi 2024 · NEW YORK, April 5, 2024 – Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today reported positive data from the maintenance phase of its phase 2b CALDOSE-1 trial of lead … hillbrush visitor centre
Immunic Therapeutics - vidofludimus calcium (IMU-838): …
Witryna21 paź 2024 · Four months after taking an axe to the pipeline resulting from a Phase II miss, Immunic is back with another miss. On Thursday afternoon, the New York … Witryna1 dzień temu · Immunic Inc CEO Dr. Daniel Vitt speaks to Proactive following the release of data from the maintenance phase of its phase... April 13, 2024 Witryna4 sie 2024 · NEW YORK, Aug. 4, 2024 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX ), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused on treating ... smart choice hsa website